D-0309-2026 Class II Ongoing
FDA drug recall D-0309-2026 was initiated by F.H. INVESTMENTS, Inc. (dba Asteria Health) on January 26, 2026 and is designated Class II. Reason for recall: Presence of Foreign substance - potential presence of metal particulate matter The recall status is ongoing. Affected quantity: 22,478 pellets..
Recall Details
- Product Type
- Drugs
- Report Date
- February 18, 2026
- Initiation Date
- January 26, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 22,478 pellets.
Product Description
ESTRADIOL, 12.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79599-3012-32.
Reason for Recall
Presence of Foreign substance - potential presence of metal particulate matter
Distribution Pattern
Nationwide in the USA
Code Information
Lot#: 253000117, Exp. 02/21/2026; 253000129, Exp. 06/12/2026; 253000130, Exp. 06/16/2026; 253000154, 253000155, Exp. 08/29/2026; 253000160, Exp. 09/10/2026.